- Drug Trials Snapshots🔍
- gmab_Ex99_1_01May20🔍
- FDA Approves Darzalex Providing a New Treatment for Patients with ...🔍
- FDA Approves Daratumumab in Combination for Frontline Multiple ...🔍
- A New Multiple Myeloma Indication for Daratumumab and ...🔍
- FDA Receives sNDA for Daratumumab Combo in Newly Diagnosed ...🔍
- Official Consumer Website🔍
- FDA Approves Daratumumab for Transplant Ineligible Myeloma pts🔍
Daratumumab Approved by FDA for Pretreated Multiple Myeloma
Drug Trials Snapshots: DARZALEX - FDA
DARZALEX is a drug used to treat patients with a form of blood cancer called multiple myeloma. It is for patients who have received at least three prior ...
Subcutaneous formulation of daratumumab, DARZALEX FASPRO™, approved by the U.S. FDA for the treatment of patients with multiple myeloma · Approval based on data ...
FDA Approves Darzalex Providing a New Treatment for Patients with ...
Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma.
FDA Approves Daratumumab in Combination for Frontline Multiple ...
On September 26, 2019, the U.S. Food and Drug Administration (FDA) approved daratumumab (Darzalex, Janssen) for adult patients with multiple myeloma in ...
A New Multiple Myeloma Indication for Daratumumab and ...
The US Food and Drug Administration (FDA) has approved daratumumab and hyaluronidase-fihj (Darzalex Faspro), plus bortezomib, lenalidomide, and dexamethasone.
FDA Receives sNDA for Daratumumab Combo in Newly Diagnosed ...
FDA Receives sNDA for Daratumumab Combo in Newly Diagnosed Multiple Myeloma ... Findings from the phase 3 PERSEUS trial support the supplemental ...
Official Consumer Website | DARZALEX® & DARZALEX FASPRO ...
DARZALEX FASPRO® is a prescription medicine used to treat adult patients with multiple myeloma: in combination with the medicines bortezomib, lenalidomide, and ...
FDA Approves Daratumumab for Transplant Ineligible Myeloma pts
Daratumumab is the first monoclonal antibody approved for newly diagnosed patients with multiple myeloma. The FDA approval of daratumumab in ...
Janssen Announces U.S. FDA Approval of DARZALEX ...
"DARZALEX® (daratumumab) Approved by the U.S. FDA in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Who Have ...
FDA Approves Split-Dosing Regimen for Daratumumab in Patients ...
On February 12, 2019, the US Food and Drug Administration (FDA) granted approval for daratumumab (Darzalex; Janssen), a CD38-directed antibody, ...
FDA Approves Split-Dosing Regimen for Daratumumab in Patients ...
... approval for the treatment of patients with MM and is the first to ... FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma.
Darzalex (Daratumumab) | International Myeloma Foundation
Darzalex (daratumumab) is the first FDA-approved monoclonal antibody that targets the CD38 protein on the surface of myeloma cells.
FDA approves daratumumab and hyaluronidase-fihj with bortezomib ...
On July 30, 2024, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj in combination with bortezomib, lenalidomide, ...
FDA Approves Daratumumab and Hyaluronidase-Fihj ... - ONS Voice
FDA Approves Daratumumab and Hyaluronidase-Fihj With Pomalidomide and Dexamethasone for Multiple Myeloma · U.S. Food and Drug Administration (FDA) ...
Darzalex Quadruplet Therapy Approved for NDMM - HealthTree
New Daratumumab-based Combination for Newly Diagnosed Myeloma ... This newly FDA-approved regimen combines daratumumab administered subcutaneously ...
Genmab A/S Announces FDA Approval Of DARZALEX ... - BioSpace
DARZALEX (daratumumab) approved by U.S. FDA for heavily pre-treated or double refractory multiple myeloma · First monoclonal antibody approved ...
FDA Approves Darzalex for Pretreated Multiple Myeloma - Cure Today
Acting four months ahead of schedule, the FDA has approved the CD38-targeted monoclonal antibody Darzalex (daratumumab) as a monotherapy for ...
Daratumumab Approved Early by FDA for Multiple Myeloma
The FDA granted an accelerated approval of the CD-38-targeted monoclonal antibody daratumumab (Darzalex)-the first monoclonal antibody to be ...
FDA approves Darzalex for patients with previously treated multiple ...
Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have ...
Latest FDA Approval Inspires Hope for Multiple Myeloma Cure
The FDA approved daratumumab (Darzalex) in combination with carfilzomib (Kyprolis) and dexamethasone to treat relapsed/refractory multiple ...